Fount Bio
Signal active
Organization
Contact Information
Overview
Fount Bio is a life science company that applies proprietary advances in glycopolymer research for skin health. The company was founded in 2018 and is headquartered in Cambridge, Massachusetts, United States.
About
Industries
Biotechnology, Pharmaceutical, Beauty
Founded
2018
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Fount Bio headquartered in United States, North America, operates in the Biotechnology, Pharmaceutical, Beauty sector. The company focuses on Biotechnology and has secured $97.9M in funding across 12 round(s). With a team of 11-50 employees, Fount Bio is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Fount Bio, raised $8.2M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
1
Investors
1
Lead Investors
0
Total Funding Amount
$8.2M
Details
1
Fount Bio has raised a total of $8.2M in funding over 1 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2021 | Early Stage Venture | 8.2M |
Investors
Fount Bio is funded by 4 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Justin Burns | - | FUNDING ROUND - Justin Burns | 8.2M |
| Anthony Aiudi | - | FUNDING ROUND - Anthony Aiudi | 8.2M |
| Fount Bio | - | FUNDING ROUND - Fount Bio | 8.2M |
| Morningside Venture Investments | - | FUNDING ROUND - Morningside Venture Investments | 8.2M |
Recent Activity
There is no recent news or activity for this profile.